Compassionate grounds C Diff treatment interview
1 year ago
4.04K
C Difficile is a gram positive, spore forming bacteria responsible for a debilitating gut infection, which infects and kills 500,000 and 30,000 North Americans respectively every year.
ImmuniMed Inc is a Winnipeg based clinical stage Biopharmaceutical company in phase 2 trials of its novel C Diff treatment. This interview records the personal experience of an individual suffering multiple recurrent C Diff infections.
Loading comments...
-
2:48
Canadian phase 2 clinical trial, recruiting patients.
1 year agoC Difficile treatment. Canadian phase 2 clinical trial, recruiting patients.
69 -
1:00
Healthprep
4 years agoWarning Signs Of A C. Difficile Infection
57.4K -
1:00
Healthprep
4 years agoThe Warning Signs Of A C. Difficile Infection
80.1K -
1:09:00
Asher Press
1 year agoDr. Sabine Hazan: The Gut Bacteria That’s Missing in People Who Get Severe COVID -FULL INTERVIEW
5.06K5 -
1:06:30
DailyCrier
2 months agoDr. Sabine Hazan - The Gut Bacteria That’s Missing in People Who Get Severe C19
249 -
1:06:30
Right2Freedom
1 year agoDr. Sabine Hazan - The Gut Bacteria That’s Missing in People Who Get Severe COVID
12.9K9 -
1:25:18
VoicesForFreedomNZ
1 year agoCourageous Convos with Dr Shankara Chetty: Observations Of A Successful Frontline Covid GP
2251 -
3:34
Thrivetime Show: The ReAwakening versus The Great Reset
3 years agoWe Now Officially Have a Cure for COVID-19 | 15 Questions with Dr. Richard Bartlett
1.01K -
1:33:54
DrSarahMyhill
6 months agoDr Sarah Myhill - The treatment of chronic infection
731 -
13:31
UnitedHealthAlliance
1 year ago6. STEW PETERS INTERVIEWS A DOCTOR THAT HAS CURED THOUSANDS OF COVID PATIENTS, JUNE 8, 2021
96